Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with…
Built on insights from 500 million devices, the open, vendor-agnostic Plume Platform unifies network intelligence and AI orchestration to engage,…
Integrated care model with advanced clinical excellence with Ayush is strengthening India's Global Appeal: Prataprao Jadhav, MoS (I/C), Health and…
LONDON, Feb. 23, 2026 /PRNewswire/ -- The newly reopened Regent Sounds guitar shop on Denmark Street will mark the launch…
NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for local flavours, Coca-Cola is bringing back its cult…
This year's edition features 20+ award categories with over 40 leading brands competing across segments. This will also be the…
CHANDIGARH, India, Feb. 12, 2026 /PRNewswire/ -- Kiteskraft Productions LLP proudly presents The Power List: Minds and Missions Redefining Success…
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…
ALPHARETTA, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- As manufacturers and distributors move beyond AI experimentation, Aptean, a global leader…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…